Kirk Ways
Equibles does not estimate personal net worth.
Get an email with a short summary when Spruce Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get SPRB alertsAbout Kirk Ways
The proxy statement of Spruce Biosciences, Inc. reports total compensation of $1,044,412 for Kirk Ways in fiscal 2025. Spruce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spruce Biosciences, Inc. includes Javier Szwarcberg (CEO and Board Member), Michael Grey (Chairman), Samir Gharib (CFO) and 3 others.
Affiliation history
-
Spruce Biosciences, Inc. (SPRB)
Proxy statement
CurrentStart not stated–present
Last confirmed April 9, 2026
Company network
Leadership on record at Spruce Biosciences, Inc.
- Javier Szwarcberg CEO, Board Member
- Michael Grey Chairman
- Samir Gharib CFO
- Keli Walbert Board Member
- Kirk Ways, M.D., Ph.D. Board Member
- Percival Barretto-Ko Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Spruce Biosciences, Inc. (SPRB) | M.D., Ph.D. Interim Chief Medical Officer | — | $1,044,412 |
Recent activity
No call appearances or filed executive changes recorded yet.